期刊文献+

HPLC测定人血清中阿米替林及去甲阿米替林的浓度 被引量:2

STIMULANEOUS DETERMINATION OF AMITRIPTYLINE AND N-DESMETHYL-AMITRIPTYLINE IN HUMAN SERUM BY HPLC
下载PDF
导出
摘要 目的:建立测定血清中阿米替林(AM)及其产物N-去甲阿米替林(N-AM)浓度HPLC法。方法:血清样品碱化后采用乙醚萃取,其有机相吹干检测。以甲醇∶乙腈∶水∶正丁胺∶冰乙酸(55∶90∶45∶2∶1.5)为流动相,检测波长为254nm,VP-ODS柱。结果:血清中阿米替林(AM)及其产物N-去甲阿米替林(N-AM)线性范围均为25-400μg/L,方法回收率分别为92.3%-125.7%及109.9%-121.8%,日内RSD分别为5.52%-7.70%及1.76%-9.46%,日间RSD分别为4.59%-7.70%及1.96%-9.59%。结论:本方法在阿米替林血药浓度监测应用上具有可操作性强,重现性好,临床监测周期短等优点,适合人体药动学研究。 Objective: To develop a method of HPLC for the simultaneous determination of Amitriptyline and its active metabolite N-desmethyl Amitriptyline in serum. Methods: N-desmethyl Amitriptyline and Amitriptyline in serum were extracted by ether and the oganic phase must blow dry to detected. The chromatographic separation was performed on the VP- ODS column using the mixture of methanol: water: butyl-Amine: glacial acetic acid( 55: 90 ∶2 ∶1. 5) as the mobile phase. The eluate was monit-ored at 229 nm. Results: The linearity was obtained over the range of 31. 25 - 500μg / Lwith the recoveries 92. 3% - 125. 7% and 109. 9% - 121. 8% for N- desmethyl Amitriptyline and Amitriptyline. respectively. The intraday RSD were 5. 52% - 7. 70% and 1. 76% - 9. 46%,and the inter-day RSD were 4. 59% - 7. 70% and 1. 96% - 9. 59%,for N-desmethyl Amitriptyline and Amitriptyline. respectively. Conclusion: The amitriptyline blood concentration has a good operability,reproducibility and short clinical monitoring periodidty,Which suit for human pharmacokinetic.
作者 赵金栓 张凯
出处 《内蒙古医科大学学报》 2014年第6期513-516,共4页 Journal of Inner Mongolia Medical University
基金 内蒙古自然科学基金项目(2009MS1155)
关键词 阿米替林 n-去甲阿米替林 高效液相色谱法 血清药物浓度 amitriptyline n-desmethyl amitriptyline HPLC serum drug concentration
  • 相关文献

参考文献4

二级参考文献23

  • 1何娟,周志凌,李焕德.HPLC-MS同时测定4种新型抗抑郁药物的血药浓度[J].药物分析杂志,2005,25(12):1428-1432. 被引量:16
  • 2Franssen EJ,Kunst PW,Bet PM,et al.Toxicokinetics of Nortriptyline and Amitriptyline:Two Case Reports[J].Ther Drug Monit,2003,25(2):248-251.
  • 3Dahlin KL,stbom L,Blomgren B,et al.Acute Lung Failure Induced by Tricyclic Antidepressants[J].Toxicol Appl Pharmacol,1997,146(2):309-316.
  • 4Preskorn SH,Jerkovich GS.Central nervous system toxicity of tricyclic antidepressants:phenomenology,course,risk factors,and role of therapeutic drug monitoring[J].J Clin Psychopharmacol,1990,10(2):88-95.
  • 5Thanacoody H K,Thomas S H.Tricyclic antidepressant poisoning:cardiovascular toxicity[J].Toxicol Rev,2005,24(3):205-214.
  • 6Thomas SHL,Bevan L,Bhattacharyya S,et al.Presentation of poisoned patients to accident and emergency departments in the North of England[J].Hum Exp Toxicol,1996,15(6):466-470.
  • 7Buckley NA,Whyte IM,Dawson AH,et al.Self-poisoning in Newcastle,1987-1992.Med J Aust 1995,162(4):190-193.
  • 8Abaut AY,Chevanne F,Le Corre P.Oral bioavailability and intestinal secretion of amitriptyline:Role of P-glycoprotein?[J].Int J Pharm,2007,330(1-2):121-128.
  • 9Uhr M,Grauer MT,Yassouridis A,et al.Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls[J].J Psychiatr Res,2007,41(1-2):179-188.
  • 10Demeule M,Jodoin J,Beaulieu E,et al.Dexamethasone modulation of multidrug transporters in normal tissues[J].FEBS Lett,1999,442(2-3):208-214.

共引文献14

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部